• Caitlin S Brown, Preeyaporn Sarangarm, Brett Faine, Megan A Rech, Tara Flack, Brian Gilbert, Gavin T Howington, Jessica Laub, Blake Porter, Giles W Slocum, Anne Zepeski, and David E Zimmerman.
• Department of Pharmacy, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States of America. Electronic address: Brown.Caitlin1@mayo.edu.
• Am J Emerg Med. 2022 Oct 1; 60: 889588-95.

AbstractThis article highlights the most relevant emergency medicine (EM) pharmacotherapy publications indexed in 2021. A modified Delphi approach was utilized for selected journals to identify the most impactful EM pharmacotherapy studies via the GRADE system. After review of journal table of contents GRADE 1A and 1B articles were reviewed by authors. Twenty articles, 2 guidelines, 2 position papers, and 2 meta-analysis were selected for full summary. Articles included in this review highlight acute agitation management, acute appendicitis treatment, sexually transmitted infection updates, optimizing sepsis management and treatment, updates for the ideal thrombolytic agent in acute ischemic stroke and endovascular therapy candidates, indications for tranexamic acid, calicium for out of hospital cardiac arrest, optimial inotrope for cardiogenic shock, awareness during rapid sequence intubation paralysis, comparison of propofol or dexmedetomidine for sedation, treatment of cannabis hyperemsis syndrome, and prophylactic use of diphenhydramine to reduce neuroleptic side effects. Selected articles are summarized to include design, results, limitations, conclusions and impact.Copyright © 2022 Elsevier Inc. All rights reserved.

11 keywords...

hide…